DAFTAR PUSTAKA

1. Sutadi, Sri M. Sirosis Hepatis. Bagian Ilmu Penyakit Dalam Fakultas

Kedokteran Universitas Sumatra Utara, Sumatra Utara, 2003. Hal 1-6

2. Nurdjanah S. Sirosis hati. Dalam: Sudoyo AW, Setiyohadi B, Alwi I,

Simadibrata M, Setiati S, editors. Buku Ajar Ilmu Penyakit Dalam. Edisi ke-
4. Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit Dalam Fakultas
Kedokteran Universitas Indonesia. 2006.

3. Perz JF, Armstrong GL, Farrington LA, Hutin YJF, Bell BP. The
Contributions of Hepatitis B virus and Hepatitis C virus Infections to
Cirrhosis and Primary Liver Cancer Worldwide. J Hepatol. 2006;45(1):529-
38.

4. World Heatlh Organization. Viral Hepatitis in the WHO South-East Asia

Region. New Delhi: WHO. 2011.

5. Sulaiman HA, Julitasari, Sie A, Rustam M, Melani W, Corwin A, Jennings

GB. Prevalence of Hepatitis B and C Viruses in Healthy Indonesian Blood
Donors. Trans R Soc Trop Med Hyg. 2008;89(1):167-70.

6. Hadi, Sudjono. Sirosis Hati dalam Gastroenterologi. Badung: Alumni, 2008.

pp:637-638.

7. Nidegger D, Ragot S, Berthelemy P, Masliah C, Pilette C, Martin T, et al.

Cirrhosis and Bleeding: The Need for Very Early Management. J Hepatol,
2003; 39(1):509-14.

8. Garcia-Tsao G, Bosch J. Management of Varices and Variceal Hemorrhage in

Cirrhosis. N engl J Med. 2010;362(2):823-32.

9. Dib N, Oberti F, Cales P. Current Management of the Complications of Portal

Hypertension: Variceal Bleeding and Asites. CMAJ. 2006; 174(3):1433-43.

10. Riley TR, Taheri M, Schreibman IR. Does Weight History Affect Fibrosis in
the Setting of Chronic Liver Disease?. J Gastrointestin Liver Dis. 2009.
18(3):299-302.

11. Kasper, Dennis. Harrison's Principles of Internal Medicine. Newyork:

McGraw-Hill Professional;2004.

12. Mulyo S. Profilaksis Primer Perdarahan Varises Gastroesofagus pada Sirosis

Hati: Peranan Penghambat Beta. CDK, 2016;43(12):940-944.
13. Thorn, Adams, Braunwald, Isselbacher, & Petersdorf. Harrison's Principles of
Internal Medicine. Edisi IX. Jakarta Utara: Penerbit Buku Kedokteran; 1991.

14. Maryani S. Sirosis Hepatis. Jurnal Penyakit Dalam. 2013;25:11–15.

15. WHO. World Health Organisation 1997-1999. Geneva: World Health

Statistics Annual;2000.

16. Ndraha. The Indonesian Journal of Gastroenterology, Hepatology, and

Digestive Endoscopy. Volume 10, Number 3; 2009.

17. Hadi, S. Gastroenterologi. Bandung: Penerbit Alumni Bandung; 2002.

18. Rasyid. Temuan Ultrasonografi Kanker Hati Hepatoseluler Hepatoma.

Majalah Kedokteran Nusantara. Volume 39 No 2; 2006.

19. Nurdjanah S. Sirosis hati. Dalam: Sudoyo WA, Setiyohadi B, Alwi I, et al,
editor. Buku ajar ilmu penyakit dalam jilid I. Edisi keempat. Jakarta: Pusat
Penerbitan Departemen Ilmu Penyakit Dalam FK UI, 2007.

20. Don C. Rockey, Scott L. Friedman. 2006. Hepatic Fibrosis And Cirrhosis.
http://www.eu.elsevierhealth.com/media/us/samplechapters/9781416032588/
9781416032588.pdf.

21. Siti Nurdjanah. Sirosis Hepatis. In: Sudoyo AW, Setiyohadi B, Alvi I,
Simadibrata MK, Setiati S (eds). Buku Ajar Ilmu Penyakit Dalam, 5th ed.
Jakarta; Departemen Ilmu Penyakit Dalam Fakultas Kedokteran Indonesia.
2009. Page 668-673.

22. Avunduk, C. Manual of Gastroenterology Diagnosis and Therapy. Edisi IV.

Philadelphia: Lippincott Williams & Wilkins; 2008.

23. Sherlock S, Dooley J. Disease of the liver and biliary system. Edisi IX.
Oxford: Blackwell Scientific Publications, 1993: 357-67.

24. Rigas B, Spiro HM. Clinical Gastroenterology: companion book. Edisi IV.
New York: Mc Graw Hill, 1995: 588-611.

25. Global Burden of Diseases in 2002 [database on the internet]. WHO Global.
2008 [cited 9 Pebruari 2014]. Available from: http://www.wpro.who.int.

26. Arguedes MR, Fallon MB. Cirrhosis of the liver and its complications. In:
Carpenter CCJ, Griggs RC, Loscalzo J, editors. Cecil essentials of medicine.
Edisi XI. Pennsylvania: Saunders, 2004: 411-7.
27. Setiawan, Poernomo Budi. Sirosis hati. In: Askandar Tjokroprawiro,
Poernomo Boedi Setiawan, et al. Buku Ajar Penyakit Dalam, Fakultas
Kedokteran Universitas Airlangga. 2007. Page 129-136.

28. Robert S. Rahimi, Don C. Rockey. Complications of Cirrhosis. Curr Opin

Gastroenterol. 2012. 28(3):223-229.

29. Price S.A. Patofisiologi konsep Klinis Proses-proses Penyakit, Edisi VI.
Jakarta: EGC; 2006.

30. Ami V, Vianto D. Faktor Risiko Terkait Perdarahan Varises Esofagus

Berulang pada Penderita Sirosis Hati. Jurnal Penyakit Dalam.2011;12(3):56–
62.

31. Escorsell A, Banares R, Garcia-Pagan JC, Gilabert R, Moitinho E, Piqueras

B, et al. TIPS versus drug therapy in preventing variceal rebleeding in
advanced cirrhosis: a randomized controlled trial. Hepatology. 2008;
35(1):385-92.

32. Franchis R. Revising consensus in portal hypertension: report of the Baveno

V consensus workshop on methodology of diagnosis and therapy in portal
hypertension. Hepatology. 2010; 53(1):762-8.

33. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. The Practice Guidelines
Committee of the American Association for the Study of Liver Diseases, the
Practice Parameters Committee of the American College of Gastroenterology.
Prevention and management of gastroesophageal varices and variceal
hemorrhage in cirrhosis. Am J Gastroenterol. 2007; 102(1):2086-102.

34. Guadalupe Garcia-Tsao. Prevention and Management of Gastroesophageal

Varices and Variceal Hemorrhage in Cirrhosis. Am J Gastroenterol. 2007.
102:2086–2102.

35. Chung, Raymond T, Padolsky K. Cirrhosis and It’s Complications. Newyork:

McGraw-Hill Companies;2003.

36. Bosch J, Garcia-Pagan JC. Prevention of variceal rebleeding. Lancet. 2008;

361(3):952-4.

37. Guo Z, Wu Z, Wang Y. Antacids for preventing oesophagogastric variceal

bleeding and rebleeding in cirrhotic patients. Cochrane Database of
Systematic Reviews. The Cochrane Library; 2008.

38. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R.
Transection of the oesophagus for bleeding oesophageal varices. Br J Surg.
2008; 60(1):646-9.
39. Moller S, Henriksen JH. Cirrhotic cardiomyopathy: a pathophysiological
review of circulatory dysfunction in liver disease. 2008; 87(1):9-15.

40. Garcia-Pagan JC, Villanueva C, Albillos A, Banares R, Morillas R, Abraldes

JG, et al. Nadolol plus isosorbide mononitrate alone or associated with band
ligation in the prevention of recurrent bleeding: a multicentre randomised
controlled trial. Gut. 2009; 58(1):1144-50.